ACTRN12605000674639尚未招募1 期
A phase 1b, multicentre study of CICRVax6 HPV6L1 VLPs as therapy for genital warts
Centre for Immunology and Cancer Research, University of Queensland0 个研究点目标入组 480 人开始时间: 2005年10月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •Patients currently have clinically diagnosed genital warts, which were initially diagnosed at least three months ago, and have persisted or recurred after at least one course of conventional destructive treatment, willing to undergo further destructive therapy.
排除标准
- •Patients have hypersensitivity to any component of the vaccine or patients currently taking systemic immunosuppressive or immunodulative medication, or topical imiquimod as wart therapy.
研究者
相似试验
尚未招募
1 期
HPV VLP as adjunct therapy for recurrent respiratory papillomatosis.ACTRN12607000016437Centre for Immunology and Cancer Research, University of Queensland36
已完成
2 期
Multicenter and Open-label Phase IIa Study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis, Patellar Tendinitis, Achilles Tendinitis and Plantar Fasciitis)Enthesopathy (Lateral Epicondylitis, Patellar Tendinitis, Achilles Tendinitis and Plantar Fasciitis)JPRN-UMIN000006014SEIKAGAKU CORPORATIO60
进行中（未招募）
不适用
A study to look for the presence of specific types of virus on genital skin swellingCTRI/2012/02/002466MSD Pharmaceuticals Pvt Ltd200
已完成
不适用
VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)Chronic Venous InsufficiencyNCT04757766Servier Russia350
进行中（未招募）
不适用
A multi-centre phase II controlled study of Vx-001 in Non Small Cell Lung Cancer (NSCLC)EUCTR2006-005032-25-GRVaxon Biotech225